Clinical Trials in New York

Showing 18961-18980 of 22,668 trials

Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load

NCT00959413

The mouth may play an important part in monitoring HIV progression. Mucosal lesions of the mouth are often the first sign of infection and their development in already diagnosed individuals indicates disease progression. In addition, saliva may provide a non-invasive way to track viral load. The purpose of this study is to establish standardized practices for examining the mouth and identifying oral mucosal lesions as well as to establish a correlation of viral load with HIV particles found in saliva.

HIV Infections

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections328 participantsStarted Sep 2009

San Francisco, California, United States • Atlanta, Georgia, United States • New York, New York, United States +3 more locations

WITHDRAWNPhase 1< 1 mile

Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression

NCT00659399

The purpose of this study is to assess feasibility and safety of using once daily Fondaparinux Sodium (ARIXTRA®) in patients with ovarian cancer who are in 'clinical remission' (no clinical evidence of disease) after chemotherapy but at high risk of ovarian cancer recurrence.

Ovarian Carcinoma

NYU Langone HealthStarted Jan 2008

New York, New York, United States

COMPLETEDPhase 1< 1 mile

Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies

NCT01688960

This is an open-label, multicenter, ascending, multiple dose study of nesvacumab (REGN910/ SAR307746) in combination with aflibercept ("ziv-aflibercept" in the U.S.)

Solid Tumors

Regeneron Pharmaceuticals48 participantsStarted Oct 2012

Indianapolis, Indiana, United States • New York, New York, United States • Oklahoma City, Oklahoma, United States +3 more locations

Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load

Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression

Nesvacumab (REGN910/ SAR307746) and Aflibercept ("Ziv-aflibercept" in the U.S.) in Patients With Advanced Solid Malignancies

Find Trials by Condition in New York

TeleQuit Smoking Cessation Program

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Seprafilm in the Reduction of Incidence of Bowel Obstruction in General Surgery

NVA237 BID Versus Placebo Twelve-week Efficacy Study

Dialysis Clinical Outcomes Revisited (DCOR) Trial

The IMPROVE Study-IMPact of a Regulated ADC System

Depression Screening in Patients Undergoing Radiation Therapy For Cancer

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Clinical Investigation of Expanded Designs of a Multifocal IOL

Study of Meloxicam Capsules to Treat Osteoarthritis Pain

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT

Identification and Validation of Biomarkers of Acute Kidney Injury Recovery

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

Patient-Reported Outcomes in Adults With Congenital Heart Disease

Fibroid Ablation Study - Large Fibroids